<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>IPOdesktop - Seeking Alpha</title>
    <description>© seekingalpha.com. Use of this feed is limited to personal, non-commercial use and is governed by Seeking Alpha's Terms of Use (http://seekingalpha.com/page/terms-of-use). Publishing this feed for public or commercial use and/or misrepresentation by a third party is prohibited.</description>
    <author>
      <name>SeekingAlpha.com</name>
    </author>
    <link>http://seekingalpha.com/author/ipodesktop</link>
    <item>
      <title>IPO Preview: Alcobra Pharmaceuticals</title>
      <link>http://seekingalpha.com/article/1448731-ipo-preview-alcobra-pharmaceuticals?source=feed</link>
      <guid isPermaLink="false">1448731</guid>
      <content>
        <![CDATA[<p>Based in Tel Aviv, Israel, <b>Alcobra Pharmaceuticals (ADHD</b><b>)</b> scheduled a $25 million IPO with a market capitalization of $133 million at a price range mid-point of $11, for Wednesday, May 22, 2013.</p><p>Five other new IPOs are scheduled for IPOs for this week. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1566049/000114420413025841/v343584_f1a.htm" rel="nofollow">F-1A</a> filed May 2, 2013</li>
  <li>Manager, Joint Managers: Aegis Capital<br/>Co Managers: Sunrise Securities</li>
</ul><p><b>SUMMARY</b><br/> ADHD is a biopharmaceutical company with a lead product targeted towards Attention Deficit Hyperactivity Disorder, or ADHD. ADHD has completed a Phase 2 study, but <a href='http://seekingalpha.com/symbol/teva' title='Teva Pharmaceutical Industries Limited'>TEVA</a> backed out of a collaboration agreement in November 2011 by not making a payment.</p><p><b>VALUATION</b> </p><div class="big_table">
  <table border="1" cellpadding="0" cellspacing="0">
    <tr>
      <td width="181" valign="top">
        <p>
          <b>Valuation Ratios</b>
        </p>
      </td>
      <td width="69" valign="top">
        <p>
          <b>IPO Mrkt</b>
        </p>
      </td>
      <td width="60" valign="top">
        <p>
          <b>Price /</b>
        </p>
      </td>
      <td width="76" valign="top">
        <p>
          <b>Price /</b>
        </p>
      </td>
      <td width="80" valign="top">
        <p>
          <b>Price /</b>
        </p>
      </td>
      <td width="93" valign="top">
        <p>
          <b>Price /</b>
        </p>
      </td>
      <td width="69" valign="top">
        <p>
          <b>% offered</b>
        </p>
      </td>
    </tr>
    <tr>
      <td width="181" valign="top">
        <p>annualizing March qtr</p>
      </td>
      <td width="69" valign="top">
        <p>
          <b>Cap &#40;MM&#41;</b>
        </p>
      </td>
      <td width="60" valign="top">
        <p>
          <b>Sales</b>
        </p>
      </td>
      <td width="76" valign="top">
        <p>
          <b>Earnings</b>
        </p>
      </td>
      <td width="80" valign="top">
        <p>
          <b>BkValue</b>
        </p>
      </td>
      <td width="93" valign="top">
        <p>
          <b>TangibleBV</b>
        </p>
      </td>
      <td width="69" valign="top">
        <p>
          <b>in IPO</b>
        </p>
      </td>
    </tr>
    <tr>
      <td width="181" valign="top">
        <p>
          <b>Alcobra Pharmaceuticals (<a href='http://seekingalpha.com/symbol/adhd' title='Alcobra'>ADHD</a>)</b>
        </p>
      </td>
      <td width="69" valign="top">
        <p>$113</p>
      </td>
      <td width="60" valign="top">
        <p>n/a</p>
      </td>
      <td width="76" valign="top">
        <p>-27.6</p>
      </td>
      <td width="80" valign="top">
        <p>5.1</p>
      </td>
      <td width="93" valign="top">
        <p>5.0</p>
      </td>
      <td width="69" valign="top">
        <p>22%</p>
      </td>
    </tr>
  </table>
</div><p>
  <a href="http://gaskinsco.com/glossary.htm" rel="nofollow">Glossary</a>
</p><p>ADHD has no revenue, 5</p>]]>
      </content>
      <pubDate>Tue, 21 May 2013 01:57:00 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Based in Tel Aviv, Israel, <b>Alcobra Pharmaceuticals (ADHD</b><b>)</b> scheduled a $25 million IPO with a market capitalization of $133 million at a price range mid-point of $11, for Wednesday, May 22, 2013.</p><p>Five other new IPOs are scheduled for IPOs for this week. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1566049/000114420413025841/v343584_f1a.htm" rel="nofollow">F-1A</a> filed May 2, 2013</li>
  <li>Manager, Joint Managers: Aegis Capital<br/>Co Managers: Sunrise Securities</li>
</ul><p><b>SUMMARY</b><br/> ADHD is a biopharmaceutical company with a lead product targeted towards Attention Deficit Hyperactivity Disorder, or ADHD. ADHD has completed a Phase 2 study, but <a href='http://seekingalpha.com/symbol/teva' title='Teva Pharmaceutical Industries Limited'>TEVA</a> backed out of a collaboration agreement in November 2011 by not making a payment.</p><p><b>VALUATION</b> </p><div class="big_table">
  <table border="1" cellpadding="0" cellspacing="0">
    <tr>
      <td width="181" valign="top">
        <p>
          <b>Valuation Ratios</b>
        </p>
      </td>
      <td width="69" valign="top">
        <p>
          <b>IPO Mrkt</b>
        </p>
      </td>
      <td width="60" valign="top">
        <p>
          <b>Price /</b>
        </p>
      </td>
      <td width="76" valign="top">
        <p>
          <b>Price /</b>
        </p>
      </td>
      <td width="80" valign="top">
        <p>
          <b>Price /</b>
        </p>
      </td>
      <td width="93" valign="top">
        <p>
          <b>Price /</b>
        </p>
      </td>
      <td width="69" valign="top">
        <p>
          <b>% offered</b>
        </p>
      </td>
    </tr>
    <tr>
      <td width="181" valign="top">
        <p>annualizing March qtr</p>
      </td>
      <td width="69" valign="top">
        <p>
          <b>Cap &#40;MM&#41;</b>
        </p>
      </td>
      <td width="60" valign="top">
        <p>
          <b>Sales</b>
        </p>
      </td>
      <td width="76" valign="top">
        <p>
          <b>Earnings</b>
        </p>
      </td>
      <td width="80" valign="top">
        <p>
          <b>BkValue</b>
        </p>
      </td>
      <td width="93" valign="top">
        <p>
          <b>TangibleBV</b>
        </p>
      </td>
      <td width="69" valign="top">
        <p>
          <b>in IPO</b>
        </p>
      </td>
    </tr>
    <tr>
      <td width="181" valign="top">
        <p>
          <b>Alcobra Pharmaceuticals (<a href='http://seekingalpha.com/symbol/adhd' title='Alcobra'>ADHD</a>)</b>
        </p>
      </td>
      <td width="69" valign="top">
        <p>$113</p>
      </td>
      <td width="60" valign="top">
        <p>n/a</p>
      </td>
      <td width="76" valign="top">
        <p>-27.6</p>
      </td>
      <td width="80" valign="top">
        <p>5.1</p>
      </td>
      <td width="93" valign="top">
        <p>5.0</p>
      </td>
      <td width="69" valign="top">
        <p>22%</p>
      </td>
    </tr>
  </table>
</div><p>
  <a href="http://gaskinsco.com/glossary.htm" rel="nofollow">Glossary</a>
</p><p>ADHD has no revenue, 5</p><br/><a href='http://seekingalpha.com/article/1448731-ipo-preview-alcobra-pharmaceuticals?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/adhd">ADHD</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>6 New IPOs Scheduled For Week Of May 20</title>
      <link>http://seekingalpha.com/article/1448531-6-new-ipos-scheduled-for-week-of-may-20?source=feed</link>
      <guid isPermaLink="false">1448531</guid>
      <content>
        <![CDATA[<p>Six new IPOs are scheduled for the week of May 20th, to raise over $1 billion. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><p>Here's a listing of this week's new IPOs, ranked by size of IPO.</p><p><b>Constellium Holdco B.V. (<a href='http://seekingalpha.com/symbol/cstm' title='Constellium'>CSTM</a>),</b> $400 million<br/> Based in Schiphol-Rijk , Netherlands, Constellium Holdco B.V. (<a href='http://seekingalpha.com/symbol/cstm' title='Constellium'>CSTM</a>) scheduled a $400 million IPO with a market capitalization of $1.8 billion at a price range mid-point of $18 for Thursday, May 23, 2013.</p><p>CSTM is a specialty metals company that participates in select segments of the aluminum semi-fabricated products industry, including rolled and extruded products.</p><p>Post-IPO, CSTM will have a retained deficit of $201 million, because Apollo (private equity firm) in its usual style has sucked out as much cash as it can through borrowings and paying dividends. CSTM also has a revenue problem: the March 2013 quarter revenue is expected to be down 2%-3% from</p>]]>
      </content>
      <pubDate>Mon, 20 May 2013 19:02:34 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Six new IPOs are scheduled for the week of May 20th, to raise over $1 billion. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><p>Here's a listing of this week's new IPOs, ranked by size of IPO.</p><p><b>Constellium Holdco B.V. (<a href='http://seekingalpha.com/symbol/cstm' title='Constellium'>CSTM</a>),</b> $400 million<br/> Based in Schiphol-Rijk , Netherlands, Constellium Holdco B.V. (<a href='http://seekingalpha.com/symbol/cstm' title='Constellium'>CSTM</a>) scheduled a $400 million IPO with a market capitalization of $1.8 billion at a price range mid-point of $18 for Thursday, May 23, 2013.</p><p>CSTM is a specialty metals company that participates in select segments of the aluminum semi-fabricated products industry, including rolled and extruded products.</p><p>Post-IPO, CSTM will have a retained deficit of $201 million, because Apollo (private equity firm) in its usual style has sucked out as much cash as it can through borrowings and paying dividends. CSTM also has a revenue problem: the March 2013 quarter revenue is expected to be down 2%-3% from</p><br/><a href='http://seekingalpha.com/article/1448531-6-new-ipos-scheduled-for-week-of-may-20?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/adhd">ADHD</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cstm">CSTM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pgem">PGEM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/brss">BRSS</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ptla">PTLA</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ecom">ECOM</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>IPO Preview: Marketo</title>
      <link>http://seekingalpha.com/article/1441321-ipo-preview-marketo?source=feed</link>
      <guid isPermaLink="false">1441321</guid>
      <content>
        <![CDATA[<p>Based in San Mateo, CA, <b>Marketo (<a href='http://seekingalpha.com/symbol/mkto' title='Marketo'>MKTO</a>)</b> scheduled a $73 million IPO with a market capitalization of $429 at a price range mid-point of $12, for Friday, May 17, 2013.</p> <p>Four other new IPOs are scheduled for this week. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p> <ul><li><a href="http://www.sec.gov/Archives/edgar/data/1490660/000104746913005541/a2214938zs-1a.htm" rel="nofollow">S-1</a> filed May 6, 2013</li>     <li>Manager, Joint Managers : Goldman, Sachs; Credit Suisse</li>     <li>Co Managers: UBS; Canaccord Genuity; Raymond James; JMP Securities</li> </ul><p>
  <strong>SUMMARY</strong>
</p> <p>MKTO provides a cloud-based marketing software platform, similar to Eloqua, which was recently acquired by Oracle for $871 million. MKTO's subscription dollar retention rate was 100% for each of 2011 and 2012. VC firms own 83% pre-IPO and are not sellers on the IPO.</p>   <p>
  <b>VALUATION</b>
</p> <p>Notice that MKTO's price-to-earnings is the same as what Oracle paid for Eloqua. Relative to that transaction, MKTO is priced at a price-sales and price-to-book value discount.</p> <table border="1" cellpadding="0" cellspacing="0">
  <tr><td width="181" valign="top"><p><b>Valuation Ratios</b></p></td>             <td width="69" valign="top"><p><b>IPO Mrkt</b></p></td>             <td width="60" valign="top"><p><b>Price /</b></p></td>             <td width="76" valign="top"><p><b>Price</b></p></td>                                                </tr>
</table>                                            ]]>
      </content>
      <pubDate>Thu, 16 May 2013 15:34:32 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Based in San Mateo, CA, <b>Marketo (<a href='http://seekingalpha.com/symbol/mkto' title='Marketo'>MKTO</a>)</b> scheduled a $73 million IPO with a market capitalization of $429 at a price range mid-point of $12, for Friday, May 17, 2013.</p> <p>Four other new IPOs are scheduled for this week. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p> <ul><li><a href="http://www.sec.gov/Archives/edgar/data/1490660/000104746913005541/a2214938zs-1a.htm" rel="nofollow">S-1</a> filed May 6, 2013</li>     <li>Manager, Joint Managers : Goldman, Sachs; Credit Suisse</li>     <li>Co Managers: UBS; Canaccord Genuity; Raymond James; JMP Securities</li> </ul><p>
  <strong>SUMMARY</strong>
</p> <p>MKTO provides a cloud-based marketing software platform, similar to Eloqua, which was recently acquired by Oracle for $871 million. MKTO's subscription dollar retention rate was 100% for each of 2011 and 2012. VC firms own 83% pre-IPO and are not sellers on the IPO.</p>   <p>
  <b>VALUATION</b>
</p> <p>Notice that MKTO's price-to-earnings is the same as what Oracle paid for Eloqua. Relative to that transaction, MKTO is priced at a price-sales and price-to-book value discount.</p> <table border="1" cellpadding="0" cellspacing="0">
  <tr><td width="181" valign="top"><p><b>Valuation Ratios</b></p></td>             <td width="69" valign="top"><p><b>IPO Mrkt</b></p></td>             <td width="60" valign="top"><p><b>Price /</b></p></td>             <td width="76" valign="top"><p><b>Price</b></p></td>                                                </tr>
</table>                                            <br/><a href='http://seekingalpha.com/article/1441321-ipo-preview-marketo?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/mkto">MKTO</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>IPO Preview: Tableau Software</title>
      <link>http://seekingalpha.com/article/1439931-ipo-preview-tableau-software?source=feed</link>
      <guid isPermaLink="false">1439931</guid>
      <content>
        <![CDATA[<p>Based in Seattle, WA, <b>Tableau Software (<a href='http://seekingalpha.com/symbol/data' title='Tableau Software'>DATA</a>)</b> scheduled a $176 million IPO with a market capitalization of $1.4 billion at a price range mid-point of $24.50, for Friday, May 17, 2013.</p><p>Four other new IPOs are scheduled for this week. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" target="_blank" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1303652/000119312513200190/d469057ds1a.htm" target="_blank" rel="nofollow">S-1</a> filed May 6, 2013</li>
  <li>Manager,Joint Managers:Goldman, Sachs; Morgan Stanley</li>
  <li>Co Managers:Credit Suisse;J.P. Morgan; UBS; BMO Capital; JMP Securities</li>
</ul><p>
  <strong>SUMMARY</strong>
</p><p>Data believes it is "democratizing" the use of business analytics software.</p><p>On a year-over-year basis DATA's sales increased 82% in 2011, 106% in 2012 and 60% in the March '13 quarter. DATA had been making marginal profits which turned in to loss for the March '13 quarter, because sales &amp; marketing jumped to $24 million from $11 million.</p><p>
  <b>VALUATION</b>
</p><p>DATA is priced at a price-to-sales premium to QLIK (a direct competitor mentioned in the S-1 filing), but DATA's March qtr sales</p>]]>
      </content>
      <pubDate>Thu, 16 May 2013 09:41:40 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Based in Seattle, WA, <b>Tableau Software (<a href='http://seekingalpha.com/symbol/data' title='Tableau Software'>DATA</a>)</b> scheduled a $176 million IPO with a market capitalization of $1.4 billion at a price range mid-point of $24.50, for Friday, May 17, 2013.</p><p>Four other new IPOs are scheduled for this week. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" target="_blank" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1303652/000119312513200190/d469057ds1a.htm" target="_blank" rel="nofollow">S-1</a> filed May 6, 2013</li>
  <li>Manager,Joint Managers:Goldman, Sachs; Morgan Stanley</li>
  <li>Co Managers:Credit Suisse;J.P. Morgan; UBS; BMO Capital; JMP Securities</li>
</ul><p>
  <strong>SUMMARY</strong>
</p><p>Data believes it is "democratizing" the use of business analytics software.</p><p>On a year-over-year basis DATA's sales increased 82% in 2011, 106% in 2012 and 60% in the March '13 quarter. DATA had been making marginal profits which turned in to loss for the March '13 quarter, because sales &amp; marketing jumped to $24 million from $11 million.</p><p>
  <b>VALUATION</b>
</p><p>DATA is priced at a price-to-sales premium to QLIK (a direct competitor mentioned in the S-1 filing), but DATA's March qtr sales</p><br/><a href='http://seekingalpha.com/article/1439931-ipo-preview-tableau-software?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/qlik">QLIK</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/data">DATA</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>IPO Preview: Tallgrass Energy Partners, LP</title>
      <link>http://seekingalpha.com/article/1431941-ipo-preview-tallgrass-energy-partners-lp?source=feed</link>
      <guid isPermaLink="false">1431941</guid>
      <content>
        <![CDATA[<p>Based in Overland Park, KS, Tallgrass Energy Partners, LP (<a href='http://seekingalpha.com/symbol/tep' title='Tallgrass Energy Partners, LP'>TEP</a>) scheduled a $287 million IPO with a market capitalization of $891 million at a price range mid-point of $22, for Tuesday, May 14, 2013.</p><p>Four other new IPOs are scheduled for this week. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li>
    <p><a href="http://www.sec.gov/Archives/edgar/data/1569134/000119312513200204/d475659ds1a.htm" rel="nofollow">S-1</a> filed May 6, 2013</p>
  </li>
  <li>
    <p>Manager, Joint Managers: Barclays; Citigroup; BofA Merrill Lynch; Deutsche Bank Securities</p>
  </li>
  <li>
    <p>Co Managers: Credit Suisse; Morgan Stanley; RBC Capital Markets; Wells Fargo Securities; Baird</p>
  </li>
</ul><p>
  <b>SUMMARY</b>
</p><p>TEP provides natural gas transportation and storage services for customers in the Rocky Mountain and Midwest regions of the United States.</p><p>TEP is a spin-off of a $3.1 billion acquisition by TheTallgrass Group from Kinder Morgan Energy Partners, L.P. (NYSE: <a href='http://seekingalpha.com/symbol/kmp' title='Kinder Morgan Energy Partners L.P'>KMP</a>), in November, 2012. The Tallgrass Group is based in Overland Park, KS</p><p><b>Excess cash generated</b><br/> TEP generated excess cash of $6.1 million over the minimum expected distribution</p>]]>
      </content>
      <pubDate>Mon, 13 May 2013 23:33:21 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Based in Overland Park, KS, Tallgrass Energy Partners, LP (<a href='http://seekingalpha.com/symbol/tep' title='Tallgrass Energy Partners, LP'>TEP</a>) scheduled a $287 million IPO with a market capitalization of $891 million at a price range mid-point of $22, for Tuesday, May 14, 2013.</p><p>Four other new IPOs are scheduled for this week. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li>
    <p><a href="http://www.sec.gov/Archives/edgar/data/1569134/000119312513200204/d475659ds1a.htm" rel="nofollow">S-1</a> filed May 6, 2013</p>
  </li>
  <li>
    <p>Manager, Joint Managers: Barclays; Citigroup; BofA Merrill Lynch; Deutsche Bank Securities</p>
  </li>
  <li>
    <p>Co Managers: Credit Suisse; Morgan Stanley; RBC Capital Markets; Wells Fargo Securities; Baird</p>
  </li>
</ul><p>
  <b>SUMMARY</b>
</p><p>TEP provides natural gas transportation and storage services for customers in the Rocky Mountain and Midwest regions of the United States.</p><p>TEP is a spin-off of a $3.1 billion acquisition by TheTallgrass Group from Kinder Morgan Energy Partners, L.P. (NYSE: <a href='http://seekingalpha.com/symbol/kmp' title='Kinder Morgan Energy Partners L.P'>KMP</a>), in November, 2012. The Tallgrass Group is based in Overland Park, KS</p><p><b>Excess cash generated</b><br/> TEP generated excess cash of $6.1 million over the minimum expected distribution</p><br/><a href='http://seekingalpha.com/article/1431941-ipo-preview-tallgrass-energy-partners-lp?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/epb">EPB</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/wpz">WPZ</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/kmp">KMP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/smlp">SMLP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tep">TEP</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>5 New IPOs Scheduled For Week Of May 13</title>
      <link>http://seekingalpha.com/article/1430741-5-new-ipos-scheduled-for-week-of-may-13?source=feed</link>
      <guid isPermaLink="false">1430741</guid>
      <content>
        <![CDATA[<p>Five new IPOs are scheduled for the week of May 13th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p> <p>Note: UBIC, Inc. (<a href='http://seekingalpha.com/symbol/ubic' title='UBIC'>UBIC</a>) &amp; Trade Street Residential (<a href='http://seekingalpha.com/symbol/tsre' title='Trade Street Residential, Inc.'>TSRE</a>) both trade on secondary markets and are not true IPOs. They are listed on some IPO calendars, however.</p> <p>Here's a listing of this week's new IPOs, ranked by size of IPO.</p> <p>
  <b>Midstream gas LP: Tallgrass Energy Partners, LP (<a href='http://seekingalpha.com/symbol/tep' title='Tallgrass Energy Partners, LP'>TEP</a>)</b>
</p> <p>Based in Overland Park, KS, Tallgrass Energy Partners, LP scheduled a $287 million IPO with a market capitalization of $891 million at a price range mid-point of $22, for Tuesday, May 14, 2013.</p> <p>TEP provides natural gas transportation and storage services for customers in the Rocky Mountain and Midwest regions of the United States.</p> <p>TEP is a spin-off of a $3.1 billion acquisition by TheTallgrass Group from Kinder Morgan Energy Partners, L.P. (NYSE: <a href='http://seekingalpha.com/symbol/kmp' title='Kinder Morgan Energy Partners L.P'>KMP</a>), in November, 2012. The Tallgrass Group is based in Overland</p>             ]]>
      </content>
      <pubDate>Mon, 13 May 2013 14:57:57 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Five new IPOs are scheduled for the week of May 13th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p> <p>Note: UBIC, Inc. (<a href='http://seekingalpha.com/symbol/ubic' title='UBIC'>UBIC</a>) &amp; Trade Street Residential (<a href='http://seekingalpha.com/symbol/tsre' title='Trade Street Residential, Inc.'>TSRE</a>) both trade on secondary markets and are not true IPOs. They are listed on some IPO calendars, however.</p> <p>Here's a listing of this week's new IPOs, ranked by size of IPO.</p> <p>
  <b>Midstream gas LP: Tallgrass Energy Partners, LP (<a href='http://seekingalpha.com/symbol/tep' title='Tallgrass Energy Partners, LP'>TEP</a>)</b>
</p> <p>Based in Overland Park, KS, Tallgrass Energy Partners, LP scheduled a $287 million IPO with a market capitalization of $891 million at a price range mid-point of $22, for Tuesday, May 14, 2013.</p> <p>TEP provides natural gas transportation and storage services for customers in the Rocky Mountain and Midwest regions of the United States.</p> <p>TEP is a spin-off of a $3.1 billion acquisition by TheTallgrass Group from Kinder Morgan Energy Partners, L.P. (NYSE: <a href='http://seekingalpha.com/symbol/kmp' title='Kinder Morgan Energy Partners L.P'>KMP</a>), in November, 2012. The Tallgrass Group is based in Overland</p>             <br/><a href='http://seekingalpha.com/article/1430741-5-new-ipos-scheduled-for-week-of-may-13?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/tep">TEP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/wlh">WLH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/data">DATA</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/mkto">MKTO</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ambi">AMBI</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>IPO Preview: NBC Bank Holding</title>
      <link>http://seekingalpha.com/article/1422041-ipo-preview-nbc-bank-holding?source=feed</link>
      <guid isPermaLink="false">1422041</guid>
      <content>
        <![CDATA[<p>Based in New Orleans, LA, First NBC Bank Holding (<a href='http://seekingalpha.com/symbol/nbcb' title='First NBC Bank'>NBCB</a>) scheduled a $100 million IPO with a market capitalization of $414 million at a price range mid-point of $24, for Friday, May 10, 2013.</p><p>Nine other IPOs were scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1496631/000119312513182577/d413833ds1a.htm" rel="nofollow">S-1</a> filed April 30, 2013.</li>
  <li>Manager, Joint Managers: Sander O'Neill; Keefe, Bruyette &amp; Woods</li>
  <li>Co Managers: Sterne Agee; FIG Partners; Monroe Financial Partners</li>
</ul><p><b>Summary</b><br/> NBCB is the largest bank by assets headquartered in New Orleans, which is fast growing. Based on the December 2012 year, the P/E is 14, based on the reported net income. The P/E is 22.9 adjusting for taxes, but NBCB is getting tax benefits from government programs.</p><p><b>Articles</b><br/><a href="http://www.nola.com/politics/index.ssf/2013/03/new_orleans_reached_81_percent.html" rel="nofollow">March 2013</a><br/> New Orleans reached 81 percent of pre-Katrina population in 2012, Census figures show.</p><p><a href="http://www.gnocdc.org/Factsforfeatures/HurricaneKatrinaRecovery/" rel="nofollow">February 2013</a><br/> New Orleans is a smaller</p>]]>
      </content>
      <pubDate>Thu, 09 May 2013 20:03:29 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Based in New Orleans, LA, First NBC Bank Holding (<a href='http://seekingalpha.com/symbol/nbcb' title='First NBC Bank'>NBCB</a>) scheduled a $100 million IPO with a market capitalization of $414 million at a price range mid-point of $24, for Friday, May 10, 2013.</p><p>Nine other IPOs were scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1496631/000119312513182577/d413833ds1a.htm" rel="nofollow">S-1</a> filed April 30, 2013.</li>
  <li>Manager, Joint Managers: Sander O'Neill; Keefe, Bruyette &amp; Woods</li>
  <li>Co Managers: Sterne Agee; FIG Partners; Monroe Financial Partners</li>
</ul><p><b>Summary</b><br/> NBCB is the largest bank by assets headquartered in New Orleans, which is fast growing. Based on the December 2012 year, the P/E is 14, based on the reported net income. The P/E is 22.9 adjusting for taxes, but NBCB is getting tax benefits from government programs.</p><p><b>Articles</b><br/><a href="http://www.nola.com/politics/index.ssf/2013/03/new_orleans_reached_81_percent.html" rel="nofollow">March 2013</a><br/> New Orleans reached 81 percent of pre-Katrina population in 2012, Census figures show.</p><p><a href="http://www.gnocdc.org/Factsforfeatures/HurricaneKatrinaRecovery/" rel="nofollow">February 2013</a><br/> New Orleans is a smaller</p><br/><a href='http://seekingalpha.com/article/1422041-ipo-preview-nbc-bank-holding?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/cnob">CNOB</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ibtx">IBTX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/nbhc">NBHC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/nbcb">NBCB</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>IPO Preview: TriState Capital Holdings</title>
      <link>http://seekingalpha.com/article/1416641-ipo-preview-tristate-capital-holdings?source=feed</link>
      <guid isPermaLink="false">1416641</guid>
      <content>
        <![CDATA[<p>Based in Pittsburgh, PA, TriState Capital Holdings (<a href='http://seekingalpha.com/symbol/tsc' title='TriState Capital'>TSC</a>) scheduled a $65.6 million IPO with a market capitalization of $320 million at a price range mid-point of $11.5, for Thursday, May 9, 2013.</p><p>Nine other IPOs were scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" target="_blank" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1380846/000119312513168284/d510409ds1a.htm" target="_blank" rel="nofollow">S-1</a> filed April 24, 2013</li>
  <li>Manager, Joint Managers: Stephens; Keefe, Bruyette &amp; Woods (A Stifel Company); Baird</li>
  <li>Co Managers: Macquarie Capital</li>
</ul><p><b>SUMMARY</b><br/> TSC is a regional bank that has achieved comparatively rapid organic, internal growth. Its rate of top line revenue growth, however, has slowed.</p><p>Comparing the 2012 year with 2011, total interest revenue grew only 9% and but profits were up 47%., and net interest income was up 21% But comparing the March 2013 quarter with the March 2012 quarter we find the net interest income is up only 8% and profits were up only 3%. That</p>]]>
      </content>
      <pubDate>Wed, 08 May 2013 19:53:48 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Based in Pittsburgh, PA, TriState Capital Holdings (<a href='http://seekingalpha.com/symbol/tsc' title='TriState Capital'>TSC</a>) scheduled a $65.6 million IPO with a market capitalization of $320 million at a price range mid-point of $11.5, for Thursday, May 9, 2013.</p><p>Nine other IPOs were scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" target="_blank" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1380846/000119312513168284/d510409ds1a.htm" target="_blank" rel="nofollow">S-1</a> filed April 24, 2013</li>
  <li>Manager, Joint Managers: Stephens; Keefe, Bruyette &amp; Woods (A Stifel Company); Baird</li>
  <li>Co Managers: Macquarie Capital</li>
</ul><p><b>SUMMARY</b><br/> TSC is a regional bank that has achieved comparatively rapid organic, internal growth. Its rate of top line revenue growth, however, has slowed.</p><p>Comparing the 2012 year with 2011, total interest revenue grew only 9% and but profits were up 47%., and net interest income was up 21% But comparing the March 2013 quarter with the March 2012 quarter we find the net interest income is up only 8% and profits were up only 3%. That</p><br/><a href='http://seekingalpha.com/article/1416641-ipo-preview-tristate-capital-holdings?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/cnob">CNOB</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ibtx">IBTX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tsc">TSC</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>IPO Preview: Quintiles Transnational Holdings</title>
      <link>http://seekingalpha.com/article/1416631-ipo-preview-quintiles-transnational-holdings?source=feed</link>
      <guid isPermaLink="false">1416631</guid>
      <content>
        <![CDATA[<p>Based in Durham, NC, Quintiles Transnational Holdings (<a href='http://seekingalpha.com/symbol/q' title='Quintiles'>Q</a>) scheduled a $750 million IPO with a market capitalization of $4.9 billion at a price range mid-point of $38 for Friday, May 10, 2013.</p><p>9 other IPOs were scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" target="_blank" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1478242/000119312513175430/d483912ds1a.htm" target="_blank" rel="nofollow">S-1</a> filed April 26, 2013</li>
  <li>Manager, Joint Managers: Morgan; Barclays; J.P. Morgan</li>
  <li>Co Managers: Citi; Goldman; Wells Fargo; BofA Merrill Lynch; Deutsche; Baird; William Blair Jefferies; Guggenheim Securities; Piper Jaffray; Raymond James; RBC Capital; UBS</li>
</ul><p><b>SUMMARY</b><br/> Q is the world's largest provider of biopharmaceutical development services and commercial outsourcing services.</p><p>It's the biggest company in the sector, but it's a low gross margin service business, with 25% gross margins.</p><p>Q has a balance sheet that's weakened by paying out lots of dividends, resulting in a negative net worth of $879 million. But in Q's case it doesn't matter</p>]]>
      </content>
      <pubDate>Wed, 08 May 2013 19:52:17 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Based in Durham, NC, Quintiles Transnational Holdings (<a href='http://seekingalpha.com/symbol/q' title='Quintiles'>Q</a>) scheduled a $750 million IPO with a market capitalization of $4.9 billion at a price range mid-point of $38 for Friday, May 10, 2013.</p><p>9 other IPOs were scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" target="_blank" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1478242/000119312513175430/d483912ds1a.htm" target="_blank" rel="nofollow">S-1</a> filed April 26, 2013</li>
  <li>Manager, Joint Managers: Morgan; Barclays; J.P. Morgan</li>
  <li>Co Managers: Citi; Goldman; Wells Fargo; BofA Merrill Lynch; Deutsche; Baird; William Blair Jefferies; Guggenheim Securities; Piper Jaffray; Raymond James; RBC Capital; UBS</li>
</ul><p><b>SUMMARY</b><br/> Q is the world's largest provider of biopharmaceutical development services and commercial outsourcing services.</p><p>It's the biggest company in the sector, but it's a low gross margin service business, with 25% gross margins.</p><p>Q has a balance sheet that's weakened by paying out lots of dividends, resulting in a negative net worth of $879 million. But in Q's case it doesn't matter</p><br/><a href='http://seekingalpha.com/article/1416631-ipo-preview-quintiles-transnational-holdings?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/q">Q</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>IPO Preview: Emerge Energy Services</title>
      <link>http://seekingalpha.com/article/1416461-ipo-preview-emerge-energy-services?source=feed</link>
      <guid isPermaLink="false">1416461</guid>
      <content>
        <![CDATA[<p>Based in Southlake, TX, Emerge Energy Services LP (<a href='http://seekingalpha.com/symbol/emes' title='Emerge Energy'>EMES</a>) scheduled a $150 million IPO with a market capitalization of $464 million at a price range mid-point of $20, for Thursday, May 9, 2013.</p><p>Nine other IPOs were scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1555177/000104746913005157/a2214576zs-1a.htm" rel="nofollow">S-1A</a> filed April 30, 2013</li>
  <li>Manager, Joint Managers: Citigroup/ BofA Merrill Lynch/ JPMorgan/ Wells Fargo Securities</li>
  <li>Co Managers: Stifel/Baird/PNC Capital Markets/Wunderlich Securities.</li>
</ul><p>
  <b>SUMMARY</b>
</p><p>EMES is a growth-oriented limited partnership recently formed by management and affiliates of Insight Equity to own, operate, acquire and develop a diversified portfolio of energy service assets. Operations are organized into two service oriented business segments:</p><p>• 65% of EBITDA - Sand, which primarily consists of mining and processing frac sand, a key component used in hydraulic fracturing of oil and natural gas wells; and</p><p>• 35% of EBITDA - Fuel Processing and Distribution,</p>]]>
      </content>
      <pubDate>Wed, 08 May 2013 19:04:04 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Based in Southlake, TX, Emerge Energy Services LP (<a href='http://seekingalpha.com/symbol/emes' title='Emerge Energy'>EMES</a>) scheduled a $150 million IPO with a market capitalization of $464 million at a price range mid-point of $20, for Thursday, May 9, 2013.</p><p>Nine other IPOs were scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1555177/000104746913005157/a2214576zs-1a.htm" rel="nofollow">S-1A</a> filed April 30, 2013</li>
  <li>Manager, Joint Managers: Citigroup/ BofA Merrill Lynch/ JPMorgan/ Wells Fargo Securities</li>
  <li>Co Managers: Stifel/Baird/PNC Capital Markets/Wunderlich Securities.</li>
</ul><p>
  <b>SUMMARY</b>
</p><p>EMES is a growth-oriented limited partnership recently formed by management and affiliates of Insight Equity to own, operate, acquire and develop a diversified portfolio of energy service assets. Operations are organized into two service oriented business segments:</p><p>• 65% of EBITDA - Sand, which primarily consists of mining and processing frac sand, a key component used in hydraulic fracturing of oil and natural gas wells; and</p><p>• 35% of EBITDA - Fuel Processing and Distribution,</p><br/><a href='http://seekingalpha.com/article/1416461-ipo-preview-emerge-energy-services?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/hclp">HCLP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/emes">EMES</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>IPO Preview: PennyMac Financial Services</title>
      <link>http://seekingalpha.com/article/1416361-ipo-preview-pennymac-financial-services?source=feed</link>
      <guid isPermaLink="false">1416361</guid>
      <content>
        <![CDATA[<p>Based in Moorpark, CA, PennyMac Financial Services (<a href='http://seekingalpha.com/symbol/pfsi' title='PennyMac Financial Services'>PFSI</a>) scheduled a $200 million IPO with a market capitalization of $2.3 billion at a price range mid-point of $18, for Thursday, May 9, 2013.</p><p>Nine other IPOs were scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1568669/000104746913005016/a2214616zs-1a.htm" rel="nofollow">S-1</a> filed April 29, 2013</li>
  <li>Manager; Joint Managers: Citi; BofA Merrill Lynch; Credit; Goldman</li>
  <li>Co Managers: Barclays; J.P. Morgan; Morgan; Wells Fargo</li>
</ul><p><b>SUMMARY</b><br/> PFSI is a mortgage packager and reseller and also has a management fee revenue stream from PennyMac Mortgage Investment Trust (<a href='http://seekingalpha.com/symbol/pmt' title='PennyMac Mortgage Investment Trust'>PMT</a>), which has a market capitalization of $1.48 billion.</p><p><b>MARCH QUARTER A DISAPPOINTMENT</b><br/> Net income decreased by $2.6 million in the quarter ended March 31, 2013, as compared to the quarter ended December 31, 2012, from $57.9 million to $55.3 million.</p><p>This was due to the effect on net gain on mortgage loans held</p>]]>
      </content>
      <pubDate>Wed, 08 May 2013 18:26:52 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Based in Moorpark, CA, PennyMac Financial Services (<a href='http://seekingalpha.com/symbol/pfsi' title='PennyMac Financial Services'>PFSI</a>) scheduled a $200 million IPO with a market capitalization of $2.3 billion at a price range mid-point of $18, for Thursday, May 9, 2013.</p><p>Nine other IPOs were scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1568669/000104746913005016/a2214616zs-1a.htm" rel="nofollow">S-1</a> filed April 29, 2013</li>
  <li>Manager; Joint Managers: Citi; BofA Merrill Lynch; Credit; Goldman</li>
  <li>Co Managers: Barclays; J.P. Morgan; Morgan; Wells Fargo</li>
</ul><p><b>SUMMARY</b><br/> PFSI is a mortgage packager and reseller and also has a management fee revenue stream from PennyMac Mortgage Investment Trust (<a href='http://seekingalpha.com/symbol/pmt' title='PennyMac Mortgage Investment Trust'>PMT</a>), which has a market capitalization of $1.48 billion.</p><p><b>MARCH QUARTER A DISAPPOINTMENT</b><br/> Net income decreased by $2.6 million in the quarter ended March 31, 2013, as compared to the quarter ended December 31, 2012, from $57.9 million to $55.3 million.</p><p>This was due to the effect on net gain on mortgage loans held</p><br/><a href='http://seekingalpha.com/article/1416361-ipo-preview-pennymac-financial-services?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/nsm">NSM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pmt">PMT</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pfsi">PFSI</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>IPO Preview: American Residential Properties</title>
      <link>http://seekingalpha.com/article/1416311-ipo-preview-american-residential-properties?source=feed</link>
      <guid isPermaLink="false">1416311</guid>
      <content>
        <![CDATA[<p>Based in Scottsdale, AZ, American Residential Properties (<a href='http://seekingalpha.com/symbol/arpi' title='American Residential Properties'>ARPI</a>) scheduled a $303 million IPO with a market capitalization of $707 million at a price range mid-point of $22, for Thursday, May 9, 2013.</p><p>Nine other IPOs were scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1548981/000119312513179715/d506126ds11a.htm" rel="nofollow">S-11A</a> filed April 26, 2013</li>
  <li>Manager, Joint Managers: Morgan; BofA Merrill Lynch; FBR; Jefferies</li>
  <li>Co Managers: Raymond James; Zelman Partners</li>
</ul><p><b>SUMMARY</b><br/> ARPI is a late entrant into the single family home REIT business. The bankers are trying to price ARPI compared with Silver Bay RealtyTrust (<a href='http://seekingalpha.com/symbol/sby' title='Silver Bay Realty Trust Corp.'>SBY</a>), which IPO'd December 13, 2012, at $18.50 and is up 3%.</p><p>The apparent publicly held leader in the field, however, is Spirit Realty Capital (<a href='http://seekingalpha.com/symbol/src' title='Spirit Realty Capital'>SRC</a>), which IPO'd September 19, 2012, at $15 and is up 42%.</p><p>The problem with pricing in comparison with SBY vs SRC is that in the last month</p>]]>
      </content>
      <pubDate>Wed, 08 May 2013 18:00:18 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Based in Scottsdale, AZ, American Residential Properties (<a href='http://seekingalpha.com/symbol/arpi' title='American Residential Properties'>ARPI</a>) scheduled a $303 million IPO with a market capitalization of $707 million at a price range mid-point of $22, for Thursday, May 9, 2013.</p><p>Nine other IPOs were scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1548981/000119312513179715/d506126ds11a.htm" rel="nofollow">S-11A</a> filed April 26, 2013</li>
  <li>Manager, Joint Managers: Morgan; BofA Merrill Lynch; FBR; Jefferies</li>
  <li>Co Managers: Raymond James; Zelman Partners</li>
</ul><p><b>SUMMARY</b><br/> ARPI is a late entrant into the single family home REIT business. The bankers are trying to price ARPI compared with Silver Bay RealtyTrust (<a href='http://seekingalpha.com/symbol/sby' title='Silver Bay Realty Trust Corp.'>SBY</a>), which IPO'd December 13, 2012, at $18.50 and is up 3%.</p><p>The apparent publicly held leader in the field, however, is Spirit Realty Capital (<a href='http://seekingalpha.com/symbol/src' title='Spirit Realty Capital'>SRC</a>), which IPO'd September 19, 2012, at $15 and is up 42%.</p><p>The problem with pricing in comparison with SBY vs SRC is that in the last month</p><br/><a href='http://seekingalpha.com/article/1416311-ipo-preview-american-residential-properties?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/sby">SBY</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/src">SRC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/arpi">ARPI</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>IPO Preview: Cyan</title>
      <link>http://seekingalpha.com/article/1416251-ipo-preview-cyan?source=feed</link>
      <guid isPermaLink="false">1416251</guid>
      <content>
        <![CDATA[<p>Based in Petaluma, CA, Cyan (<a href='http://seekingalpha.com/symbol/cyni' title='Cyan Inc.'>CYNI</a>) scheduled an $88 million IPO with a market capitalization of $486 million at a price range mid-point of $15, for Thursday, May 9, 2013.</p><p>Nine other IPOs were scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1391636/000119312513173678/d439911ds1a.htm" rel="nofollow">S-1</a> filed April 25, 2013</li>
  <li>Manager Joint Managers: Goldman; JPMorgan</li>
  <li>Co Managers: Jefferies; Pacific Crest Securities.</li>
</ul><p><b>SUMMARY</b><br/> CYNI pioneered innovative carrier-grade networking solutions that transform disparate and inefficient legacy networks into open high-performance networks.</p><p>Revenues are increasing at a fast clip: up 85% in the March 2013 quarter compared to March 2012. But one customer accounted for 47% of revenue, and that customer indicates they will be reducing their purchases.</p><p>At the same time CYNI's losses are increasing. If revenue growth decreases and losses increase it's not a pretty picture for CYNI. Gross profit is low for a high-tech business,</p>]]>
      </content>
      <pubDate>Wed, 08 May 2013 17:42:30 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Based in Petaluma, CA, Cyan (<a href='http://seekingalpha.com/symbol/cyni' title='Cyan Inc.'>CYNI</a>) scheduled an $88 million IPO with a market capitalization of $486 million at a price range mid-point of $15, for Thursday, May 9, 2013.</p><p>Nine other IPOs were scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1391636/000119312513173678/d439911ds1a.htm" rel="nofollow">S-1</a> filed April 25, 2013</li>
  <li>Manager Joint Managers: Goldman; JPMorgan</li>
  <li>Co Managers: Jefferies; Pacific Crest Securities.</li>
</ul><p><b>SUMMARY</b><br/> CYNI pioneered innovative carrier-grade networking solutions that transform disparate and inefficient legacy networks into open high-performance networks.</p><p>Revenues are increasing at a fast clip: up 85% in the March 2013 quarter compared to March 2012. But one customer accounted for 47% of revenue, and that customer indicates they will be reducing their purchases.</p><p>At the same time CYNI's losses are increasing. If revenue growth decreases and losses increase it's not a pretty picture for CYNI. Gross profit is low for a high-tech business,</p><br/><a href='http://seekingalpha.com/article/1416251-ipo-preview-cyan?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/cyni">CYNI</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>IPO Preview: Receptos</title>
      <link>http://seekingalpha.com/article/1415961-ipo-preview-receptos?source=feed</link>
      <guid isPermaLink="false">1415961</guid>
      <content>
        <![CDATA[<p>Based in San Diego, CA, Receptos (<a href='http://seekingalpha.com/symbol/rcpt' title='Receptos, Inc.'>RCPT</a>) scheduled a $71 million IPO with a market capitalization of $257 million at a price range mid-point of $15, for Thursday, May 9, 2013.</p><p>Nine other IPOs were scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1463729/000104746913004886/a2214466zs-1a.htm" rel="nofollow">S-1</a> filed April 25, 2013</li>
  <li>Manager, Joint Managers: Credit Suisse; Leerink Swann; BMO Capital</li>
  <li>Co Managers: Wedbush PacGrow Life Sciences.</li>
</ul><p>
  <b>SUMMARY</b>
</p><p>RCPY is a biopharma still in stage 2 clinical trials with a long road ahead<span>. RCPY lost $18 million in 2012 and has no product sales, but does have collaboration revenue.</span></p><table border="1" cellpadding="0" cellspacing="0">
  <tr>
    <td width="181" valign="top">
      <p>
        <b>Valuation Ratios</b>
      </p>
    </td>
    <td width="69" valign="top">
      <p>
        <b>IPO Mrkt</b>
      </p>
    </td>
    <td width="60" valign="top">
      <p>
        <b>Price /</b>
      </p>
    </td>
    <td width="76" valign="top">
      <p>
        <b>Price /</b>
      </p>
    </td>
    <td width="80" valign="top">
      <p>
        <b>Price /</b>
      </p>
    </td>
    <td width="93" valign="top">
      <p>
        <b>Price /</b>
      </p>
    </td>
    <td width="69" valign="top">
      <p>
        <b>% offered</b>
      </p>
    </td>
  </tr>
  <tr>
    <td width="181" valign="top">
      <p>annualized Q1 '13 estimate</p>
    </td>
    <td width="69" valign="top">
      <p>
        <b>Cap &#40;MM&#41;</b>
      </p>
    </td>
    <td width="60" valign="top">
      <p>
        <b>Sales</b>
      </p>
    </td>
    <td width="76" valign="top">
      <p>
        <b>Earnings</b>
      </p>
    </td>
    <td width="80" valign="top">
      <p>
        <b>BookVlue</b>
      </p>
    </td>
    <td width="93" valign="top">
      <p>
        <b>TangibleBV</b>
      </p>
    </td>
    <td width="69" valign="top">
      <p>
        <b>in IPO</b>
      </p>
    </td>
  </tr>
  <tr>
    <td width="181" valign="top">
      <p>
        <b>Receptos (RCPY)</b>
      </p>
    </td>
    <td width="69" valign="top">
      <p>$257</p>
    </td>
    <td width="60" valign="top">
      <p>30</p>
    </td>
    <td width="76" valign="top">
      <p>-14</p>
    </td>
    <td width="80" valign="top">
      <p>3.1</p>
    </td>
    <td width="93" valign="top">
      <p>3.0</p>
    </td>
    <td width="69" valign="top">
      <p>27%</p>
    </td>
  </tr>
</table><p>
  <a href="http://gaskinsco.com/glossary.htm" rel="nofollow">Glossary</a>
</p><p><b>CONCLUSION</b><br/> Pass on the RCPY IPO.</p><p><b>BUSINESS</b><br/> RCPY is a</p>]]>
      </content>
      <pubDate>Wed, 08 May 2013 16:47:00 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Based in San Diego, CA, Receptos (<a href='http://seekingalpha.com/symbol/rcpt' title='Receptos, Inc.'>RCPT</a>) scheduled a $71 million IPO with a market capitalization of $257 million at a price range mid-point of $15, for Thursday, May 9, 2013.</p><p>Nine other IPOs were scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1463729/000104746913004886/a2214466zs-1a.htm" rel="nofollow">S-1</a> filed April 25, 2013</li>
  <li>Manager, Joint Managers: Credit Suisse; Leerink Swann; BMO Capital</li>
  <li>Co Managers: Wedbush PacGrow Life Sciences.</li>
</ul><p>
  <b>SUMMARY</b>
</p><p>RCPY is a biopharma still in stage 2 clinical trials with a long road ahead<span>. RCPY lost $18 million in 2012 and has no product sales, but does have collaboration revenue.</span></p><table border="1" cellpadding="0" cellspacing="0">
  <tr>
    <td width="181" valign="top">
      <p>
        <b>Valuation Ratios</b>
      </p>
    </td>
    <td width="69" valign="top">
      <p>
        <b>IPO Mrkt</b>
      </p>
    </td>
    <td width="60" valign="top">
      <p>
        <b>Price /</b>
      </p>
    </td>
    <td width="76" valign="top">
      <p>
        <b>Price /</b>
      </p>
    </td>
    <td width="80" valign="top">
      <p>
        <b>Price /</b>
      </p>
    </td>
    <td width="93" valign="top">
      <p>
        <b>Price /</b>
      </p>
    </td>
    <td width="69" valign="top">
      <p>
        <b>% offered</b>
      </p>
    </td>
  </tr>
  <tr>
    <td width="181" valign="top">
      <p>annualized Q1 '13 estimate</p>
    </td>
    <td width="69" valign="top">
      <p>
        <b>Cap &#40;MM&#41;</b>
      </p>
    </td>
    <td width="60" valign="top">
      <p>
        <b>Sales</b>
      </p>
    </td>
    <td width="76" valign="top">
      <p>
        <b>Earnings</b>
      </p>
    </td>
    <td width="80" valign="top">
      <p>
        <b>BookVlue</b>
      </p>
    </td>
    <td width="93" valign="top">
      <p>
        <b>TangibleBV</b>
      </p>
    </td>
    <td width="69" valign="top">
      <p>
        <b>in IPO</b>
      </p>
    </td>
  </tr>
  <tr>
    <td width="181" valign="top">
      <p>
        <b>Receptos (RCPY)</b>
      </p>
    </td>
    <td width="69" valign="top">
      <p>$257</p>
    </td>
    <td width="60" valign="top">
      <p>30</p>
    </td>
    <td width="76" valign="top">
      <p>-14</p>
    </td>
    <td width="80" valign="top">
      <p>3.1</p>
    </td>
    <td width="93" valign="top">
      <p>3.0</p>
    </td>
    <td width="69" valign="top">
      <p>27%</p>
    </td>
  </tr>
</table><p>
  <a href="http://gaskinsco.com/glossary.htm" rel="nofollow">Glossary</a>
</p><p><b>CONCLUSION</b><br/> Pass on the RCPY IPO.</p><p><b>BUSINESS</b><br/> RCPY is a</p><br/><a href='http://seekingalpha.com/article/1415961-ipo-preview-receptos?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/rcpt">RCPT</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>IPO Preview: Armada Hoffler Properties</title>
      <link>http://seekingalpha.com/article/1411251-ipo-preview-armada-hoffler-properties?source=feed</link>
      <guid isPermaLink="false">1411251</guid>
      <content>
        <![CDATA[<p>Based in Virginia Beach, VA, Armada Hoffler Properties (<a href='http://seekingalpha.com/symbol/ahh' title='Armada Hoffler Properties, Inc.'>AHH</a>) scheduled a $175 million IPO with a market capitalization of $333.5 million at a price range mid-point of $12, for Wednesday, May 8, 2013.</p><p>10 other IPOs are scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1569187/000119312513175008/d508588ds11a.htm" rel="nofollow">S-11A</a> filed April 6, 2013</li>
  <li>Manager, Joint Managers: Baird; Raymond James; Stifel</li>
  <li>Co Managers: Oppenheimer, BB&amp;T Capit<span>al, Janney</span> Montgomery Scott, Wunderlich</li>
</ul><p>
  <strong>SUMMARY</strong>
</p><p>Post IPO AHH plans on paying a dividend of $.63 per share, which is 5.25% on an annualized basis at the price range mid-point of $12.</p><p>However, 47% of AHH's proforma 2012 revenue came from general contracting. There has never been a REIT in history with such a high revenue percentage coming from general contracting.</p><p>Also, the price-to-tangible book value is too high, at 5.9.</p><div class="big_table">
  <div class="zoom_table"> </div>
  <table border="1" cellpadding="0" cellspacing="0">
    <tr>
      <td width="181" valign="top">
        <p>
          <b>Valuation Ratios</b>
        </p>
      </td>
      <td width="69" valign="top">
        <p>
          <b>IPO Mrkt</b>
        </p>
      </td>
      <td width="60" valign="top">
        <p>
          <b>Price /</b>
        </p>
      </td>
      <td width="76" valign="top">
        <p>
          <b>Price /</b>
        </p>
      </td>
      <td width="80" valign="top">
        <p>
          <b>Price</b>
        </p>
      </td>
    </tr>
  </table>
</div>]]>
      </content>
      <pubDate>Tue, 07 May 2013 17:54:51 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Based in Virginia Beach, VA, Armada Hoffler Properties (<a href='http://seekingalpha.com/symbol/ahh' title='Armada Hoffler Properties, Inc.'>AHH</a>) scheduled a $175 million IPO with a market capitalization of $333.5 million at a price range mid-point of $12, for Wednesday, May 8, 2013.</p><p>10 other IPOs are scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1569187/000119312513175008/d508588ds11a.htm" rel="nofollow">S-11A</a> filed April 6, 2013</li>
  <li>Manager, Joint Managers: Baird; Raymond James; Stifel</li>
  <li>Co Managers: Oppenheimer, BB&amp;T Capit<span>al, Janney</span> Montgomery Scott, Wunderlich</li>
</ul><p>
  <strong>SUMMARY</strong>
</p><p>Post IPO AHH plans on paying a dividend of $.63 per share, which is 5.25% on an annualized basis at the price range mid-point of $12.</p><p>However, 47% of AHH's proforma 2012 revenue came from general contracting. There has never been a REIT in history with such a high revenue percentage coming from general contracting.</p><p>Also, the price-to-tangible book value is too high, at 5.9.</p><div class="big_table">
  <div class="zoom_table"> </div>
  <table border="1" cellpadding="0" cellspacing="0">
    <tr>
      <td width="181" valign="top">
        <p>
          <b>Valuation Ratios</b>
        </p>
      </td>
      <td width="69" valign="top">
        <p>
          <b>IPO Mrkt</b>
        </p>
      </td>
      <td width="60" valign="top">
        <p>
          <b>Price /</b>
        </p>
      </td>
      <td width="76" valign="top">
        <p>
          <b>Price /</b>
        </p>
      </td>
      <td width="80" valign="top">
        <p>
          <b>Price</b>
        </p>
      </td>
    </tr>
  </table>
</div><br/><a href='http://seekingalpha.com/article/1411251-ipo-preview-armada-hoffler-properties?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/ahh">AHH</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>10 New IPOS Scheduled For Week Of May 6</title>
      <link>http://seekingalpha.com/article/1409441-10-new-ipos-scheduled-for-week-of-may-6?source=feed</link>
      <guid isPermaLink="false">1409441</guid>
      <content>
        <![CDATA[<p>Ten new IPOs are scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p> <p>
  <strong>TW</strong>
  <b>O BIOPHARMA</b>
</p> <p>
  <b>Quintiles Transnational Holdings (<a href='http://seekingalpha.com/symbol/q' title='Quintiles'>Q</a>)</b>
</p> <p>Based in Durham, NC, Quintiles Transnational Holdings scheduled a $750 million IPO with a market capitalization of $4.9 billion at a price range mid-point of $38 for Thursday, May 9, 2013.</p> <p>Q is the world's largest provider of biopharmaceutical development services and commercial outsourcing services. It's the biggest company in the sector, but it's a low gross margin service business, with 25% gross margins.</p> <p>
  <b>Receptos (<a href='http://seekingalpha.com/symbol/rcpt' title='Receptos, Inc.'>RCPT</a>)</b>
</p> <p>Based in San Diego, CA, Receptos scheduled a $71 million IPO with a market capitalization of $257 million at a price range mid-point of $15, for Thursday, May 9, 2013.</p> <p>RCPY is a biopharma still in stage 2 clinical trials with a long road ahead of them. RCPY lost $18 million in 2012 and has no product sales.</p> <p>
  <b>THREE</b>
</p>                          ]]>
      </content>
      <pubDate>Tue, 07 May 2013 13:31:06 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Ten new IPOs are scheduled for the week of May 6th. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p> <p>
  <strong>TW</strong>
  <b>O BIOPHARMA</b>
</p> <p>
  <b>Quintiles Transnational Holdings (<a href='http://seekingalpha.com/symbol/q' title='Quintiles'>Q</a>)</b>
</p> <p>Based in Durham, NC, Quintiles Transnational Holdings scheduled a $750 million IPO with a market capitalization of $4.9 billion at a price range mid-point of $38 for Thursday, May 9, 2013.</p> <p>Q is the world's largest provider of biopharmaceutical development services and commercial outsourcing services. It's the biggest company in the sector, but it's a low gross margin service business, with 25% gross margins.</p> <p>
  <b>Receptos (<a href='http://seekingalpha.com/symbol/rcpt' title='Receptos, Inc.'>RCPT</a>)</b>
</p> <p>Based in San Diego, CA, Receptos scheduled a $71 million IPO with a market capitalization of $257 million at a price range mid-point of $15, for Thursday, May 9, 2013.</p> <p>RCPY is a biopharma still in stage 2 clinical trials with a long road ahead of them. RCPY lost $18 million in 2012 and has no product sales.</p> <p>
  <b>THREE</b>
</p>                          <br/><a href='http://seekingalpha.com/article/1409441-10-new-ipos-scheduled-for-week-of-may-6?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/q">Q</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ahh">AHH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/arpi">ARPI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pfsi">PFSI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/nbcb">NBCB</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tsc">TSC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/emes">EMES</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cyni">CYNI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/rcpt">RCPT</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>IPO Preview: BioAmber</title>
      <link>http://seekingalpha.com/article/1396241-ipo-preview-bioamber?source=feed</link>
      <guid isPermaLink="false">1396241</guid>
      <content>
        <![CDATA[<p>Based in Plymouth, MN, BioAmber (<a href='http://seekingalpha.com/symbol/bioa' title='BioAmber'>BIOA</a>) scheduled a $128 million IPO with a market capitalization of $294 million at a price range mid-point of $16 for Friday, May 3, 2013.</p><p>BIOS is one of five new IPOs scheduled for the week of April 29. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1534287/000119312513152682/d442100ds1a.htm" rel="nofollow">S-1</a> filed April 12, 2013.</li>
  <li>Manager, Joint Managers: Credit Suisse</li>
  <li>Co Managers: Société Générale; Barclays; Pacific Crest Securities.</li>
</ul><p><b>Summary</b><br/> BioAmber converts renewable feedstocks into chemicals that are replacements for petroleum-derived products. BIOA generated $15 million in sales for 2012, but lost $39 million. BIOA also expects to sell 43% of itself on the IPO, which is an high percentage and may limit future financing opportunities.</p><p>Four other companies that process renewable feedstocks to make substitutes for petroleum-based products have all traded down since their IPOs: Amyris Inc (<a href='http://seekingalpha.com/symbol/amrs' title='Amyris, Inc.'>AMRS</a>), Gevo, Inc. (<a href='http://seekingalpha.com/symbol/gevo' title='Gevo, Inc.'>GEVO</a>), KiOR Inc (<a href='http://seekingalpha.com/symbol/kior' title='KiOR, Inc.'>KIOR</a>) and Solazyme Inc</p>]]>
      </content>
      <pubDate>Thu, 02 May 2013 17:48:48 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Based in Plymouth, MN, BioAmber (<a href='http://seekingalpha.com/symbol/bioa' title='BioAmber'>BIOA</a>) scheduled a $128 million IPO with a market capitalization of $294 million at a price range mid-point of $16 for Friday, May 3, 2013.</p><p>BIOS is one of five new IPOs scheduled for the week of April 29. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1534287/000119312513152682/d442100ds1a.htm" rel="nofollow">S-1</a> filed April 12, 2013.</li>
  <li>Manager, Joint Managers: Credit Suisse</li>
  <li>Co Managers: Société Générale; Barclays; Pacific Crest Securities.</li>
</ul><p><b>Summary</b><br/> BioAmber converts renewable feedstocks into chemicals that are replacements for petroleum-derived products. BIOA generated $15 million in sales for 2012, but lost $39 million. BIOA also expects to sell 43% of itself on the IPO, which is an high percentage and may limit future financing opportunities.</p><p>Four other companies that process renewable feedstocks to make substitutes for petroleum-based products have all traded down since their IPOs: Amyris Inc (<a href='http://seekingalpha.com/symbol/amrs' title='Amyris, Inc.'>AMRS</a>), Gevo, Inc. (<a href='http://seekingalpha.com/symbol/gevo' title='Gevo, Inc.'>GEVO</a>), KiOR Inc (<a href='http://seekingalpha.com/symbol/kior' title='KiOR, Inc.'>KIOR</a>) and Solazyme Inc</p><br/><a href='http://seekingalpha.com/article/1396241-ipo-preview-bioamber?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/amrs">AMRS</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/szym">SZYM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/gevo">GEVO</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/kior">KIOR</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/bioa">BIOA</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>IPO Preview: QIWI Plc</title>
      <link>http://seekingalpha.com/article/1396141-ipo-preview-qiwi-plc?source=feed</link>
      <guid isPermaLink="false">1396141</guid>
      <content>
        <![CDATA[<p>Based in Cyprus with main offices in Moscow, 117587, RU, <b>QIWI plc (<a href='http://seekingalpha.com/symbol/qiwi' title='QIWI plc'>QIWI</a>)</b> scheduled a $204 million IPO with a market capitalization of $884 million at a price range mid-point of $17 for Friday, May 3, 2013.</p><p>QIWI is one of five new IPOs scheduled for the week of April 29. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1561566/000119312513161884/d426593df1a.htm" rel="nofollow">F-1A</a> filed April 19, 2013</li>
  <li>Manager, Joint Managers: J.P. Morgan, Credit Suisse</li>
  <li>Co Managers: Baird, RenCap, William Blair.</li>
</ul><p><b>Summary</b><br/> QIWI is a payment processing company with significant growth in the reloadable debit card and mobile wallet segments. The "wallet" segment accounted for 30% of the business and grew 80% in 2012 vs. 2011. The other segments grew 14% in 2012 vs. 2011.</p><p>100% of the IPO proceeds are to selling shareholders for 23% of the company -- this is a negative.</p><p>QIWI targets the cash-based market in Russia, which</p>]]>
      </content>
      <pubDate>Thu, 02 May 2013 17:35:39 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Based in Cyprus with main offices in Moscow, 117587, RU, <b>QIWI plc (<a href='http://seekingalpha.com/symbol/qiwi' title='QIWI plc'>QIWI</a>)</b> scheduled a $204 million IPO with a market capitalization of $884 million at a price range mid-point of $17 for Friday, May 3, 2013.</p><p>QIWI is one of five new IPOs scheduled for the week of April 29. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1561566/000119312513161884/d426593df1a.htm" rel="nofollow">F-1A</a> filed April 19, 2013</li>
  <li>Manager, Joint Managers: J.P. Morgan, Credit Suisse</li>
  <li>Co Managers: Baird, RenCap, William Blair.</li>
</ul><p><b>Summary</b><br/> QIWI is a payment processing company with significant growth in the reloadable debit card and mobile wallet segments. The "wallet" segment accounted for 30% of the business and grew 80% in 2012 vs. 2011. The other segments grew 14% in 2012 vs. 2011.</p><p>100% of the IPO proceeds are to selling shareholders for 23% of the company -- this is a negative.</p><p>QIWI targets the cash-based market in Russia, which</p><br/><a href='http://seekingalpha.com/article/1396141-ipo-preview-qiwi-plc?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/gdot">GDOT</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ntsp">NTSP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/yndx">YNDX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/qiwi">QIWI</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>IPO Preview: ING U.S.</title>
      <link>http://seekingalpha.com/article/1392821-ipo-preview-ing-u-s?source=feed</link>
      <guid isPermaLink="false">1392821</guid>
      <content>
        <![CDATA[<p>Based in New York, NY, ING U.S. (<a href='http://seekingalpha.com/symbol/voya' title='ING U.S. '>VOYA</a>) scheduled a $1.45 billion IPO with a market capitalization of $5.8 billion at a price range mid-point of $22.50, for Thursday, May 2, 2013.</p><p>VOYA is one of five new IPOs scheduled for the week of April 29. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1535929/000119312513156812/0001193125-13-156812-index.htm" rel="nofollow">S-1</a> filed April 16, 2013</li>
  <li>Manager, Joint Managers: Morgan Stanley; Goldman; Citi; BofA Merrill Lynch; Credit Suisse; Deutsche Bank; J.P. Morgan.</li>
  <li>Co Managers: ING; Barclays; RBC Capital; SunTrust Robinson Humphrey/ Evercore/ Keefe, Bruyette &amp; Woods; Raymond James; Sandler O'Neill; Wells Fargo; BNP PARIBAS; BNY Mellon; COMMERZBANK; HSBC; Mediobanca; Piper Jaffray; Ramirez; Williams Capital.</li>
</ul><p><b>Summary</b><br/> VOYA is an investment, life insurance spin-off, carve-out of Dutch-based ING, which has a market capitalization above $30 billion.</p><p>Earnings were positive in 2012, and trailing 12-months P/E multiple is 12.5, based on the income allocated to VOYA.</p><p>Benefits and expenses</p>]]>
      </content>
      <pubDate>Thu, 02 May 2013 05:28:27 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Based in New York, NY, ING U.S. (<a href='http://seekingalpha.com/symbol/voya' title='ING U.S. '>VOYA</a>) scheduled a $1.45 billion IPO with a market capitalization of $5.8 billion at a price range mid-point of $22.50, for Thursday, May 2, 2013.</p><p>VOYA is one of five new IPOs scheduled for the week of April 29. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1535929/000119312513156812/0001193125-13-156812-index.htm" rel="nofollow">S-1</a> filed April 16, 2013</li>
  <li>Manager, Joint Managers: Morgan Stanley; Goldman; Citi; BofA Merrill Lynch; Credit Suisse; Deutsche Bank; J.P. Morgan.</li>
  <li>Co Managers: ING; Barclays; RBC Capital; SunTrust Robinson Humphrey/ Evercore/ Keefe, Bruyette &amp; Woods; Raymond James; Sandler O'Neill; Wells Fargo; BNP PARIBAS; BNY Mellon; COMMERZBANK; HSBC; Mediobanca; Piper Jaffray; Ramirez; Williams Capital.</li>
</ul><p><b>Summary</b><br/> VOYA is an investment, life insurance spin-off, carve-out of Dutch-based ING, which has a market capitalization above $30 billion.</p><p>Earnings were positive in 2012, and trailing 12-months P/E multiple is 12.5, based on the income allocated to VOYA.</p><p>Benefits and expenses</p><br/><a href='http://seekingalpha.com/article/1392821-ipo-preview-ing-u-s?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/voya">VOYA</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
    <item>
      <title>IPO Preview: Insys Therapeutics</title>
      <link>http://seekingalpha.com/article/1392441-ipo-preview-insys-therapeutics?source=feed</link>
      <guid isPermaLink="false">1392441</guid>
      <content>
        <![CDATA[<p>Based in Chandler, AZ, Insys Therapeutics (<a href='http://seekingalpha.com/symbol/insy' title='INSYS Therapeutics, Inc.'>INSY</a>) scheduled a $68 million IPO with a market capitalization of $287 million at a price range mid-point of $17, for Thursday, May 2, 2013.</p><p>INSY is one of five new IPOs scheduled for the week of April 29. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1516479/000119312513162799/d153565ds1a.htm" rel="nofollow">S-1</a> filed April 19, 2013</li>
  <li>Manager, Joint Managers: Wells Fargo Securities, JMP Securities</li>
  <li>Co-Managers: Oppenheimer &amp; Co.</li>
</ul><p><b>SUMMARY</b><br/> INSY is a generic drug company whose products help reduce chemo and cancer pain. INSY lost $24 million in 2012 but expects to turn a $750,000 profit for the March 2013 quarter on almost $11 million in sales.</p><table border="1" cellpadding="0" cellspacing="0">
  <tr>
    <td width="226" valign="top">
      <p>
        <b>Valuation Ratios</b>
      </p>
    </td>
    <td width="87" valign="top">
      <p>
        <b>IPO Mrkt</b>
      </p>
    </td>
    <td width="75" valign="top">
      <p>
        <b>Price /</b>
      </p>
    </td>
    <td width="95" valign="top">
      <p>
        <b>Price /</b>
      </p>
    </td>
    <td width="100" valign="top">
      <p>
        <b>Price /</b>
      </p>
    </td>
    <td width="116" valign="top">
      <p>
        <b>Price /</b>
      </p>
    </td>
    <td width="87" valign="top">
      <p>
        <b>% offered</b>
      </p>
    </td>
  </tr>
  <tr>
    <td width="226" valign="top">
      <p>annualizing Q1 '13 estimate</p>
    </td>
    <td width="87" valign="top">
      <p>
        <b>Cap (<a href='http://seekingalpha.com/symbol/mm' title='Millennial Media, Inc.'>MM</a>)</b>
      </p>
    </td>
    <td width="75" valign="top">
      <p>
        <b>Sales</b>
      </p>
    </td>
    <td width="95" valign="top">
      <p>
        <b>Ernings</b>
      </p>
    </td>
    <td width="100" valign="top">
      <p>
        <b>BkVlue</b>
      </p>
    </td>
    <td width="116" valign="top">
      <p>
        <b>TangibleBV</b>
      </p>
    </td>
    <td width="87" valign="top">
      <p>
        <b>in IPO</b>
      </p>
    </td>
  </tr>
  <tr>
    <td width="226" valign="top">
      <p>
        <b>Insys Therapeutics</b>
      </p>
    </td>
    <td width="87" valign="top">
      <p>$289</p>
    </td>
    <td width="75" valign="top">
      <p>6.6</p>
    </td>
    <td width="95" valign="top">
      <p>96.3</p>
    </td>
    <td width="100" valign="top">
      <p>5.4</p>
    </td>
    <td width="116" valign="top">
      <p>5.3</p>
    </td>
    <td width="87" valign="top">
      <p>24%</p>
    </td>
  </tr>
</table><p>
  <a href="http://gaskinsco.com/glossary.htm" rel="nofollow">Glossary</a>
</p><p><strong>Observations</strong><br/>Annualizing INSY's expected March</p>]]>
      </content>
      <pubDate>Thu, 02 May 2013 00:21:03 -0400</pubDate>
      <author>IPOdesktop</author>
      <description>
        <![CDATA[<strong>By <a href='http://ipodesktop.com/'>IPOdesktop</a>: </strong><p>Based in Chandler, AZ, Insys Therapeutics (<a href='http://seekingalpha.com/symbol/insy' title='INSYS Therapeutics, Inc.'>INSY</a>) scheduled a $68 million IPO with a market capitalization of $287 million at a price range mid-point of $17, for Thursday, May 2, 2013.</p><p>INSY is one of five new IPOs scheduled for the week of April 29. The full IPO calendar is <a href="http://ipopremium.com/?page_id=147" rel="nofollow">here</a>.</p><ul>
  <li><a href="http://www.sec.gov/Archives/edgar/data/1516479/000119312513162799/d153565ds1a.htm" rel="nofollow">S-1</a> filed April 19, 2013</li>
  <li>Manager, Joint Managers: Wells Fargo Securities, JMP Securities</li>
  <li>Co-Managers: Oppenheimer &amp; Co.</li>
</ul><p><b>SUMMARY</b><br/> INSY is a generic drug company whose products help reduce chemo and cancer pain. INSY lost $24 million in 2012 but expects to turn a $750,000 profit for the March 2013 quarter on almost $11 million in sales.</p><table border="1" cellpadding="0" cellspacing="0">
  <tr>
    <td width="226" valign="top">
      <p>
        <b>Valuation Ratios</b>
      </p>
    </td>
    <td width="87" valign="top">
      <p>
        <b>IPO Mrkt</b>
      </p>
    </td>
    <td width="75" valign="top">
      <p>
        <b>Price /</b>
      </p>
    </td>
    <td width="95" valign="top">
      <p>
        <b>Price /</b>
      </p>
    </td>
    <td width="100" valign="top">
      <p>
        <b>Price /</b>
      </p>
    </td>
    <td width="116" valign="top">
      <p>
        <b>Price /</b>
      </p>
    </td>
    <td width="87" valign="top">
      <p>
        <b>% offered</b>
      </p>
    </td>
  </tr>
  <tr>
    <td width="226" valign="top">
      <p>annualizing Q1 '13 estimate</p>
    </td>
    <td width="87" valign="top">
      <p>
        <b>Cap (<a href='http://seekingalpha.com/symbol/mm' title='Millennial Media, Inc.'>MM</a>)</b>
      </p>
    </td>
    <td width="75" valign="top">
      <p>
        <b>Sales</b>
      </p>
    </td>
    <td width="95" valign="top">
      <p>
        <b>Ernings</b>
      </p>
    </td>
    <td width="100" valign="top">
      <p>
        <b>BkVlue</b>
      </p>
    </td>
    <td width="116" valign="top">
      <p>
        <b>TangibleBV</b>
      </p>
    </td>
    <td width="87" valign="top">
      <p>
        <b>in IPO</b>
      </p>
    </td>
  </tr>
  <tr>
    <td width="226" valign="top">
      <p>
        <b>Insys Therapeutics</b>
      </p>
    </td>
    <td width="87" valign="top">
      <p>$289</p>
    </td>
    <td width="75" valign="top">
      <p>6.6</p>
    </td>
    <td width="95" valign="top">
      <p>96.3</p>
    </td>
    <td width="100" valign="top">
      <p>5.4</p>
    </td>
    <td width="116" valign="top">
      <p>5.3</p>
    </td>
    <td width="87" valign="top">
      <p>24%</p>
    </td>
  </tr>
</table><p>
  <a href="http://gaskinsco.com/glossary.htm" rel="nofollow">Glossary</a>
</p><p><strong>Observations</strong><br/>Annualizing INSY's expected March</p><br/><a href='http://seekingalpha.com/article/1392441-ipo-preview-insys-therapeutics?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/insy">INSY</category>
      <category type="author" link="http://seekingalpha.com/author/ipodesktop">IPOdesktop</category>
    </item>
  </channel>
</rss>
